Cargando…

Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways

Obstructive sleep apnea (OSA) associated chronic kidney disease is mainly caused by chronic intermittent hypoxia (CIH) triggered tissue damage. Receptor for advanced glycation end product (RAGE) and its ligand high mobility group box 1 (HMGB1) are expressed on renal cells and mediate inflammatory re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xu, Gu, Wenyu, Lu, Huan, Liu, Chengying, Yu, Biyun, Xu, Hui, Tang, Yaodong, Li, Shanqun, Zhou, Jian, Shao, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027322/ https://www.ncbi.nlm.nih.gov/pubmed/27688824 http://dx.doi.org/10.1155/2016/1015390

Ejemplares similares

NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea
por: Wu, Xu, et al.
Publicado: (2021)

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
por: Guo, Caixia, et al.
Publicado: (2012)

Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways
por: Shi, Long, et al.
Publicado: (2013)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
por: Taneja, Sakshi, et al.
Publicado: (2021)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Levistilide A Ameliorates NLRP3 Expression Involving the Syk-p38/JNK Pathway and Peripheral Obliterans in Rats
por: Guo, Huining, et al.
Publicado: (2018)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
por: Wang, Jun, et al.
Publicado: (2022)

Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression
por: Hao, Shengyu, et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End Product Is Involved in the Inflammatory Response of Human Adenovirus-Infected Patients
por: Xu, Wen, et al.
Publicado: (2022)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia
por: Yin, Xue, et al.
Publicado: (2015)

Retracted: Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling
por: Immunology Research, Journal of
Publicado: (2023)

DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation
por: Zhang, Long-Qing, et al.
Publicado: (2022)

Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
por: Xie, Baocheng, et al.
Publicado: (2021)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
por: Hoffman, William H., et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Downregulation of the Cd38-Cyclic ADP-Ribose Signaling in Cardiomyocytes by Intermittent Hypoxia via Pten Upregulation
por: Takasawa, Shin, et al.
Publicado: (2022)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

Sesamin Ameliorates Advanced Glycation End Products-Induced Pancreatic β-Cell Dysfunction and Apoptosis
por: Kong, Xiang, et al.
Publicado: (2015)

Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney
por: Do, Moon Ho, et al.
Publicado: (2018)

Hyperoside Downregulates the Receptor for Advanced Glycation End Products (RAGE) and Promotes Proliferation in ECV304 Cells via the c-Jun N-Terminal Kinases (JNK) Pathway Following Stimulation by Advanced Glycation End-Products In Vitro
por: Zhang, Zhengyu, et al.
Publicado: (2013)

Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011)

Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
por: Tuinman, Pieter R, et al.
Publicado: (2013)

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women
por: Zaki, Moushira, et al.
Publicado: (2017)

Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic Colitis
por: Bramhall, Michael, et al.
Publicado: (2020)

The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts
por: Mitran, Cristina Iulia, et al.
Publicado: (2019)

Protective Effects of the Soluble Receptor for Advanced Glycation End-Products on Pyroptosis during Myocardial Ischemia-Reperfusion
por: Liu, Yingming, et al.
Publicado: (2021)

Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns
por: Go, Hayato, et al.
Publicado: (2021)

Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
por: Kim, Chan Ho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ulqs0tc902l3ph3dkb2pgkg5ja